According to Guardant’s website, Medicare Part B (Medical Insurance) covers a blood-based biomarker screening test to check for colorectal cancer if the individual is between the ages of 45–85, shows ...
New Study Shows at-Home Colon Cancer Screening Test Reduces Risk of Colorectal Cancer Death, as Effective as Screening Colonoscopy July 25, 2024 — A noninvasive colorectal cancer screening test ...
Colorectal cancer is the third-most common type of cancer around the world. In the earlier stages, it can be tough to catch. The symptoms, like diarrhea, abdominal pain and anemia, can easily be ...
Mainz Biomed has announced a partnership with Quest Diagnostics to support the commercialisation of its NextGen colorectal cancer screening test, ColoAlert. The test leverages polymerase chain ...
Mainz Biomed’s stool-based ColoAlert test is designed to detect colorectal cancer tumor DNA ... with more than 1.9 million new cases reported in 2020, according to World Cancer Research Fund.
Cases of colorectal cancer have been rapidly increasing among young adults. Though the disease, which affects fewer than 1% of adults, is still rare, the spike in incidence has made early screening ...